Long-term safety of immunomodulators in pediatric inflammatory diseases.

about

The European Hematology Association Roadmap for European Hematology Research: a consensus document Pharmacological treatments and infectious diseases in pediatric inflammatory bowel disease.

P2860

Q28830861-55D82F16-2DE6-4AD6-85DC-C3D9FF985A8C Q41989273-DC8541D1-158B-4A17-A375-BA3F82ADB5C3

P2860

Long-term safety of immunomodulators in pediatric inflammatory diseases.

Item

http://www.wikidata.org/entity/Q38232338

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Long-term safety of immunomodulators in pediatric inflammatory diseases.

@en

type

Item

label

Long-term safety of immunomodulators in pediatric inflammatory diseases.

@en

prefLabel

Long-term safety of immunomodulators in pediatric inflammatory diseases.

@en

P1476

Long-term safety of immunomodulators in pediatric inflammatory diseases.

@en

P2093

Federica Nuti

http://www.w3.org/2001/XMLSchema#string

P2860

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease

A practical guide to vaccinating the inflammatory bowel disease patient.

Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis.

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis.

Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease

Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry.

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.

The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study.

P2888

s40272-014-0084-2

P304

343-352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40272-014-0084-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Salvatore Cucchiara

Fortunata Civitelli

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264126391

http://www.w3.org/2001/XMLSchema#string

P6179

1021470516

http://www.w3.org/2001/XMLSchema#string

P698

25047730

http://www.w3.org/2001/XMLSchema#string

Long-term safety of immunomodulators in pediatric inflammatory diseases.

about

P2860

P2860

Long-term safety of immunomodulators in pediatric inflammatory diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698